XL44, an hRpn13 binder, induces hRpn13-dependent apoptosis and also restricts cell viability by a PCLAF-dependent mechanism. XL44 induces ubiquitin-dependent loss of hRpn13Pru and ubiquitin-independent loss of select KEN box containing proteins[1].

XPA Human Pre-designed siRNA Set A contains three designed siRNAs for XPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPC Human Pre-designed siRNA Set A contains three designed siRNAs for XPC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPC-5462 is a NaV1.6 and NaV1.2 inhibitor with the IC50s of 10.9 nM and 10.3 nM, respectively. XPC-5462 suppresses epileptiform activity in an ex vivo brain slice seizure model[1].

XPC-7724 is a selective Nav1.6 channel inhibitor with a IC50 value of 0.078 μM. XPC-7724 can be used in the study of neurological diseases[1].

XPC-7724 is a selective Nav1.6 channel inhibitor with a IC50 value of 0.078 μM. XPC-7724 can be used in the study of neurological diseases[1].

XPC-7724 is a selective Nav1.6 channel inhibitor with a IC50 value of 0.078 μM. XPC-7724 can be used in the study of neurological diseases[1].

XPC-7724 is a selective Nav1.6 channel inhibitor with a IC50 value of 0.078 μM. XPC-7724 can be used in the study of neurological diseases[1].

XPhos (2-(Dicyclohexylphosphino)-2′,4′,6′-triisopropylbiphenyl) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

XPhos (2-(Dicyclohexylphosphino)-2′,4′,6′-triisopropylbiphenyl) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

XPNPEP1 Human Pre-designed siRNA Set A contains three designed siRNAs for XPNPEP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPNPEP2 Human Pre-designed siRNA Set A contains three designed siRNAs for XPNPEP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPNPEP3 Human Pre-designed siRNA Set A contains three designed siRNAs for XPNPEP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPO1 Human Pre-designed siRNA Set A contains three designed siRNAs for XPO1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPO4 Human Pre-designed siRNA Set A contains three designed siRNAs for XPO4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPO5 Human Pre-designed siRNA Set A contains three designed siRNAs for XPO5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPO6 Human Pre-designed siRNA Set A contains three designed siRNAs for XPO6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPO7 Human Pre-designed siRNA Set A contains three designed siRNAs for XPO7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPOT Human Pre-designed siRNA Set A contains three designed siRNAs for XPOT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XPR1 Human Pre-designed siRNA Set A contains three designed siRNAs for XPR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC1 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC2 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC3 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC4 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC5 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRCC6 Human Pre-designed siRNA Set A contains three designed siRNAs for XRCC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRD-0394 is a potent and specific dual inhibitor of ATM and DNA-PKcs with oral activity. XRD-0394 significantly enhances tumor cell killing in vitro and in vivo under therapeutic ionizing radiation conditions. In addition, XRD-0394 can potentiate the effects of PARP and topoisomerase I inhibitors in vitro[1].

XRN1 Human Pre-designed siRNA Set A contains three designed siRNAs for XRN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRN2 Human Pre-designed siRNA Set A contains three designed siRNAs for XRN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XRRA1 Human Pre-designed siRNA Set A contains three designed siRNAs for XRRA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XXYLT1 Human Pre-designed siRNA Set A contains three designed siRNAs for XXYLT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XYD190 (Compound 14g) is an orally active degrader for CBP/p300. XYD190 inhibits CBP/p300 bromodomain with IC50 of 483.7 nM. XYD190 exhibits antitumor activity against acute myeloid leukemia. (Structure: Pink, CBP/p300 ligand 4 (HY-161495); Blue, E3 ligase ligand (HY-14658); Black: linker (HY-161496))[1].

XYD198 (Compound 14h) is an orally active degrader for CBP/p300. XYD198 inhibits CBP/p300 bromodomain with IC50 of 213.5 nM. XYD198 exhibits antitumor activity against acute myeloid leukemia. (Structure: Pink, CBP/p300 ligand 4 (HY-161495); Blue, E3 ligase ligand (HY-14658); Black: linker (HY-161499))[1]

XYLB Human Pre-designed siRNA Set A contains three designed siRNAs for XYLB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Xylenol blue is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also […]

Xylometazoline (hydrochloride) (Standard) is the analytical standard of Xylometazoline (hydrochloride). This product is intended for research and analytical applications. Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].

Xylometazoline-d4 hydrochloride is deuterated labeled Xylometazoline hydrochloride (HY-B0475). Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].

XYLT1 Human Pre-designed siRNA Set A contains three designed siRNAs for XYLT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

XYLT2 Human Pre-designed siRNA Set A contains three designed siRNAs for XYLT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Y-29794 tosylate is a selective, orally active inhibitor for non-peptide prolyl endopeptidase (PPCE), with an IC50 of 3 nM and a Ki of 0.95 nM. Y-29794 tosylate enhances the effect of thyrotropin-releasing hormone (TRH) on the release of ACh in the rat hippocampus, exhibits potential neuroprotective efficacy. Y-29794 tosylate exhibits anticancer activity through inhibition of […]

YAE1 Human Pre-designed siRNA Set A contains three designed siRNAs for YAE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

YAF2 Human Pre-designed siRNA Set A contains three designed siRNAs for YAF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.